| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 8.027 | 12.450 | 12.703 | 12.989 | 16.068 | 20.407 |
| Total Income - EUR | - | - | - | - | 8.027 | 12.450 | 12.703 | 12.989 | 16.068 | 20.407 |
| Total Expenses - EUR | - | - | - | - | 645 | 839 | 825 | 745 | 971 | 911 |
| Gross Profit/Loss - EUR | - | - | - | - | 7.381 | 11.612 | 11.878 | 12.245 | 15.096 | 19.496 |
| Net Profit/Loss - EUR | - | - | - | - | 7.141 | 11.262 | 11.497 | 11.855 | 12.681 | 16.377 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Alkebsi Ortomed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | 7.631 | 12.150 | 12.389 | 11.951 | 13.373 | 17.351 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 7.524 | 11.814 | 12.058 | 9.863 | 9.479 | 13.047 |
| Cash | - | - | - | - | 107 | 335 | 331 | 2.088 | 3.893 | 4.304 |
| Shareholders Funds | - | - | - | - | 7.183 | 11.321 | 11.545 | 11.918 | 12.729 | 16.425 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 448 | 828 | 844 | 33 | 643 | 927 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Alkebsi Ortomed S.r.l.